CoQ10, as well as glimepiride and their combination brought the GLUT2 level down, via improving the hyperglycemia/hyperinsulinemia-associated metabolic disorders including dyslipidemia and the activation of PI3K. The gene discussed is SLC2A2; the disease is Hyperinsulinemia.